Published in Brain on April 01, 2010
Glioblastoma stem-like cells give rise to tumour endothelium. Nature (2010) 6.18
Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci U S A (2011) 3.45
Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications. Clin Cancer Res (2012) 1.52
Advances in tenascin-C biology. Cell Mol Life Sci (2011) 1.50
Mechanisms of glioma-associated neovascularization. Am J Pathol (2012) 1.39
Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme. J Mol Med (Berl) (2013) 1.31
Direct in vivo evidence for tumor propagation by glioblastoma cancer stem cells. PLoS One (2011) 1.29
Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation. J Biol Chem (2012) 1.16
Laminin alpha 2 enables glioblastoma stem cell growth. Ann Neurol (2012) 1.13
Clinical significance of vasculogenic mimicry in human gliomas. J Neurooncol (2011) 1.11
Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas. J Neurosci (2012) 1.10
Neoplastic cells are a rare component in human glioblastoma microvasculature. Oncotarget (2012) 1.09
A new perspective of vasculogenic mimicry: EMT and cancer stem cells (Review). Oncol Lett (2013) 1.09
Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol (2013) 1.07
Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma. J Clin Oncol (2015) 1.06
Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma. CNS Oncol (2013) 1.05
Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by Glioma stem-like cells. PLoS One (2013) 1.05
Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry. BMC Cancer (2012) 1.02
Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2. Oncotarget (2015) 1.01
Advanced research on vasculogenic mimicry in cancer. J Cell Mol Med (2015) 1.00
Activation of alternative pathways of angiogenesis and involvement of stem cells following anti-angiogenesis treatment in glioma. Histol Histopathol (2012) 0.99
Cancer: Tumour stem cells switch sides. Nature (2010) 0.98
Aberrant signaling pathways in glioma. Cancers (Basel) (2011) 0.96
HER2/neu expression correlates with vasculogenic mimicry in invasive breast carcinoma. J Cell Mol Med (2012) 0.96
Suppressor of fused (Sufu) represses Gli1 transcription and nuclear accumulation, inhibits glioma cell proliferation, invasion and vasculogenic mimicry, improving glioma chemo-sensitivity and prognosis. Oncotarget (2014) 0.95
Vasculogenic mimicry: a novel target for glioma therapy. Chin J Cancer (2013) 0.95
CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia. Neuro Oncol (2013) 0.94
A target for antiangiogenic therapy: vascular endothelium derived from glioblastoma. Proc Natl Acad Sci U S A (2011) 0.93
A Matrigel-based tube formation assay to assess the vasculogenic activity of tumor cells. J Vis Exp (2011) 0.92
Neurovascular development and links to disease. Cell Mol Life Sci (2013) 0.92
A pilot histomorphology and hemodynamic of vasculogenic mimicry in gallbladder carcinomas in vivo and in vitro. J Exp Clin Cancer Res (2011) 0.90
Pivotal role of pervasive neoplastic and stromal cells reprogramming in circulating tumor cells dissemination and metastatic colonization. Cancer Microenviron (2014) 0.90
Glioma Stem Cells: Signaling, Microenvironment, and Therapy. Stem Cells Int (2016) 0.88
Tumor-specific chromosome mis-segregation controls cancer plasticity by maintaining tumor heterogeneity. PLoS One (2013) 0.87
The LIM-only transcription factor LMO2 determines tumorigenic and angiogenic traits in glioma stem cells. Cell Death Differ (2015) 0.87
Endothelial progenitor cells (EPCs) as gene carrier system for rat model of human glioma. PLoS One (2012) 0.86
Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma. Carcinogenesis (2013) 0.85
Transforming growth factor-β is required for vasculogenic mimicry formation in glioma cell line U251MG. Cancer Biol Ther (2011) 0.85
Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets. Stem Cells Int (2016) 0.85
Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization. Oncotarget (2015) 0.83
Zoledronic acid inhibits vasculogenic mimicry in murine osteosarcoma cell line in vitro. BMC Musculoskelet Disord (2011) 0.83
Histone deacetylase 3 expression correlates with vasculogenic mimicry through the phosphoinositide3-kinase / ERK-MMP-laminin5γ2 signaling pathway. Cancer Sci (2015) 0.83
Decoding the cancer stem cell hypothesis in glioblastoma. CNS Oncol (2013) 0.82
Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets. PLoS One (2013) 0.81
Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets. Biomark Res (2015) 0.81
Prominin 1/CD133 endothelium sustains growth of proneural glioma. PLoS One (2013) 0.81
Vascular Mimicry: Concepts and Implications for Anti-Angiogenic Therapy. Curr Angiogenes (2012) 0.80
Tumor refractoriness to anti-VEGF therapy. Oncotarget (2016) 0.80
Modulation of tumor tolerance in primary central nervous system malignancies. Clin Dev Immunol (2012) 0.79
Disrupting the CXCL12/CXCR4 axis disturbs the characteristics of glioblastoma stem-like cells of rat RG2 glioblastoma. Cancer Cell Int (2013) 0.79
A new mosaic pattern in glioma vascularization: exogenous endothelial progenitor cells integrating into the vessels containing tumor-derived endothelial cells. Oncotarget (2014) 0.79
All-trans retinoic acid impairs the vasculogenic mimicry formation ability of U87 stem-like cells through promoting differentiation. Mol Med Rep (2015) 0.78
Endocan: a novel circulating proteoglycan. Indian J Pharmacol (2014) 0.78
B16-F10 melanoma cells contribute to the new formation of blood vessels in the chick embryo chorioallantoic membrane through vasculogenic mimicry. Clin Exp Med (2012) 0.78
Number of glioma polyploid giant cancer cells (PGCCs) associated with vasculogenic mimicry formation and tumor grade in human glioma. J Exp Clin Cancer Res (2013) 0.78
Vascular Mimicry: The Next Big Glioblastoma Target. Biochem Physiol (2015) 0.78
Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer. Oncotarget (2015) 0.77
Antitumor activity of dichloroacetate on C6 glioma cell: in vitro and in vivo evaluation. Onco Targets Ther (2013) 0.77
Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities. BMC Cancer (2013) 0.77
Registered report: tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Elife (2015) 0.77
Conantokin-G attenuates detrimental effects of NMDAR hyperactivity in an ischemic rat model of stroke. PLoS One (2015) 0.77
Galunisertib inhibits glioma vasculogenic mimicry formation induced by astrocytes. Sci Rep (2016) 0.76
Integrative Network Analysis Combined with Quantitative Phosphoproteomics Reveals Transforming Growth Factor-beta Receptor type-2 (TGFBR2) as a Novel Regulator of Glioblastoma Stem Cell Properties. Mol Cell Proteomics (2015) 0.76
Unveiling YKL-40, from Serum Marker to Target Therapy in Glioblastoma. Front Oncol (2014) 0.76
Therapeutic targeting of cancer stem cells. Front Oncol (2011) 0.76
I. Embryonal vasculature formation recapitulated in transgenic mammary tumor spheroids implanted pseudo-orthotopicly into mouse dorsal skin fold: the organoblasts concept. F1000Res (2013) 0.76
Inhibitory effects of B-cell lymphoma 2 on the vasculogenic mimicry of hypoxic human glioma cells. Exp Ther Med (2014) 0.75
Dual Receptor Recognizing Cell Penetrating Peptide for Selective Targeting, Efficient Intratumoral Diffusion and Synthesized Anti-Glioma Therapy. Theranostics (2016) 0.75
Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies. Histol Histopathol (2016) 0.75
Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy. Front Pharmacol (2016) 0.75
Angiogenesis in glioblastoma: just another moving target? Brain (2010) 0.75
Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin. Mol Cancer (2017) 0.75
Neuro-oncology: tumor-derived blood vessels--a new therapy target? Nat Rev Neurol (2010) 0.75
Tumor-associated macrophages induce vasculogenic mimicry of glioblastoma multiforme through cyclooxygenase-2 activation. Oncotarget (2016) 0.75
Effects of HCG on human epithelial ovarian cancer vasculogenic mimicry formation in vivo. Oncol Lett (2016) 0.75
Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic response. Oncotarget (2015) 0.75
Vascular Transdifferentiation in the CNS: A Focus on Neural and Glioblastoma Stem-Like Cells. Stem Cells Int (2016) 0.75
Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells. Autophagy (2017) 0.75
Malignant pericytes expressing GT198 give rise to tumor cells through angiogenesis. Oncotarget (2017) 0.75
Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma. Transl Oncol (2017) 0.75
Endothelium-Independent Primitive Myxoid Vascularization Creates Invertebrate-Like Channels to Maintain Blood Supply in Optic Gliomas. Am J Pathol (2017) 0.75
Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression. Proc Natl Acad Sci U S A (2017) 0.75
The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol (2007) 49.11
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med (1997) 32.63
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res (2004) 14.73
Phase II trial of bevacizumab and irinotecan in recurrent malignant glioma. Clin Cancer Res (2007) 9.21
Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science (1999) 9.18
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol (2008) 8.79
Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol (1999) 7.66
Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res (1977) 5.19
Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene (2004) 4.29
Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A (2000) 3.16
In vitro proliferation of cells derived from adult human beta-cells revealed by cell-lineage tracing. Diabetes (2008) 2.64
Multiple roles of EPH receptors and ephrins in neural development. Nat Rev Neurosci (2001) 2.61
Primary glioblastomas express mesenchymal stem-like properties. Mol Cancer Res (2006) 2.18
Neural guidance molecules regulate vascular remodeling and vessel navigation. Genes Dev (2005) 2.01
Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma. Cancer Res (2001) 1.99
The growth of the blood supply to melanoma transplants in the hamster cheek pouch. Lab Invest (1966) 1.94
Vasculogenic mimicry. APMIS (2004) 1.76
Integrins and angiogenesis: a sticky business. Exp Cell Res (2005) 1.69
Vasculogenic mimicry and pseudo-comedo formation in breast cancer. Int J Cancer (2002) 1.69
BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas. Int J Cancer (2008) 1.66
Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells. J Natl Cancer Inst (2004) 1.49
Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia. Cancer Res (2005) 1.49
Mesenchymal differentiation of glioblastoma stem cells. Cell Death Differ (2008) 1.48
Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis (2008) 1.39
Does vasculogenic mimicry exist in astrocytoma? J Histochem Cytochem (2005) 1.37
Discovery of semaphorin receptors, neuropilin and plexin, and their functions in neural development. J Neurobiol (2004) 1.32
Expression of multiple molecular phenotypes by aggressive melanoma tumor cells: role in vasculogenic mimicry. Crit Rev Oncol Hematol (2002) 1.32
Cell contact regulates fate choice by cortical stem cells. J Neurosci (2000) 1.29
A novel eGFP-expressing immunodeficient mouse model to study tumor-host interactions. FASEB J (2008) 1.29
Angiogenesis and vascular remodeling by intussusception: from form to function. News Physiol Sci (2003) 1.21
Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research. Am J Pathol (2001) 1.19
Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. Cancer Res (2002) 1.19
In vitro assay of primary astrocyte migration as a tool to study Rho GTPase function in cell polarization. Methods Enzymol (2006) 1.18
Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors. Dev Dyn (2007) 1.16
Blood flow influences vascular growth during tumour angiogenesis. Br J Cancer (1999) 1.12
Pepsin pretreatment allows collagen IV immunostaining of blood vessels in adult mouse brain. J Neurosci Methods (2007) 1.12
Endothelial cells of tumor vessels: abnormal but not absent. Cancer Metastasis Rev (2000) 1.11
The vascular system of xenotransplanted tumors--scanning electron and light microscopic studies. Scanning Microsc (1989) 1.07
Incorporation of bone marrow-derived Flk-1-expressing CD34+ cells in the endothelium of tumor vessels in the mouse brain. Neurosurgery (2006) 1.05
Arrested neural and advanced mesenchymal differentiation of glioblastoma cells-comparative study with neural progenitors. BMC Cancer (2009) 1.03
Contractile responses of smooth muscle cells differentiated from rat neural stem cells. J Physiol (2002) 0.99
Tumor sinuses- vascular channels. Pathol Oncol Res (2000) 0.97
Array-based genomics in glioma research. Brain Pathol (2009) 0.90
Ultrastructure of the Lewis lung carcinoma. Eur J Cancer Clin Oncol (1982) 0.87
Transdifferentiation of rat fetal brain stem cells into penile smooth muscle cells. BJU Int (2009) 0.87
Laminin-5 promotes neurite outgrowth from central and peripheral chick embryonic neurons. Neurosci Lett (2001) 0.86
Vessels of intraocular malignant melanomas. Am J Ophthalmol (1979) 0.84
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol (2009) 25.96
Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet (2009) 7.62
Radiotherapy for glioblastoma in the elderly. N Engl J Med (2007) 5.64
Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation. Nature (2008) 5.15
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol (2009) 5.06
Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951. J Clin Oncol (2012) 4.70
The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci U S A (2007) 4.52
The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. Nature (2004) 3.77
High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood (2012) 3.44
IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group. Clin Cancer Res (2010) 3.13
Primary brain tumours in adults. Lancet (2003) 3.05
Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. Nat Med (2010) 2.88
Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development (2002) 2.68
Continuous growth of mean tumor diameter in a subset of grade II gliomas. Ann Neurol (2003) 2.43
Flow regulates arterial-venous differentiation in the chick embryo yolk sac. Development (2003) 2.43
Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology (2014) 2.38
Primary brain tumours in adults. Lancet (2012) 2.37
Axon guidance molecules in vascular patterning. Cold Spring Harb Perspect Biol (2010) 2.37
ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Dev Cell (2012) 2.14
Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation. Proc Natl Acad Sci U S A (2013) 2.10
VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat Cell Biol (2011) 2.09
Identification and functional analysis of endothelial tip cell-enriched genes. Blood (2010) 2.02
Guidance of vascular development: lessons from the nervous system. Circ Res (2009) 2.00
Skull-base metastases. J Neurooncol (2005) 2.00
MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951. J Clin Oncol (2009) 1.99
Genome-wide association study of glioma and meta-analysis. Hum Genet (2012) 1.96
Leptomeningeal metastases from solid malignancy: a review. J Neurooncol (2005) 1.94
Activation of the UNC5B receptor by Netrin-1 inhibits sprouting angiogenesis. Genes Dev (2007) 1.86
A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood (2005) 1.86
Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. Brain (2003) 1.85
Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet (2011) 1.83
A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. Cytokine Growth Factor Rev (2005) 1.81
Vasculogenic mimicry. APMIS (2004) 1.76
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile. Mol Cancer (2008) 1.72
Health-related quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for Research and Treatment of Cancer randomized clinical trial. J Clin Oncol (2007) 1.72
Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J Cell Biol (2010) 1.72
Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas. Neuro Oncol (2009) 1.68
Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice. Neuro Oncol (2012) 1.68
BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas. Int J Cancer (2008) 1.66
Accessing key steps of human tumor progression in vivo by using an avian embryo model. Proc Natl Acad Sci U S A (2005) 1.65
Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire. J Clin Oncol (2008) 1.65
Genetic risk profiles identify different molecular etiologies for glioma. Clin Cancer Res (2010) 1.59
Dural metastases. J Neurooncol (2005) 1.56
ASPM-associated stem cell proliferation is involved in malignant progression of gliomas and constitutes an attractive therapeutic target. Cancer Cell Int (2010) 1.54
Recurrent mutations of MYD88 and TBL1XR1 in primary central nervous system lymphomas. Clin Cancer Res (2012) 1.54
What determines blood vessel structure? Genetic prespecification vs. hemodynamics. Physiology (Bethesda) (2006) 1.53
CNS complications of radiotherapy and chemotherapy. Lancet (2009) 1.51
Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis (2002) 1.50
Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann Neurol (2007) 1.48
NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat (2010) 1.47